Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD

The ability of posttransplant cyclophosphamide (PTCY) to facilitate haploidentical transplantation has spurred interest in whether PTCY can improve clinical outcomes in patients with HLA-matched unrelated donors undergoing peripheral blood stem cell transplantation (PBSCT). We investigated our insti...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, Katie, Ho, Vincent T., Inyang, Eno, Cutler, Corey, Koreth, John, Shapiro, Roman M., Gooptu, Mahasweta, Romee, Rizwan, Nikiforow, Sarah, Antin, Joseph H., Wu, Catherine J., Ritz, Jerome, Soiffer, Robert J., Kim, Haesook T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405198/
https://www.ncbi.nlm.nih.gov/pubmed/37156098
http://dx.doi.org/10.1182/bloodadvances.2023009791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405198/
https://www.ncbi.nlm.nih.gov/pubmed/37156098
http://dx.doi.org/10.1182/bloodadvances.2023009791

Ejemplares similares